News

The proof-of-concept trial was conducted with Activaero’s drug-device combination consisting of budesonide in liquid formulation and the company’s proprietary controlled inhalation system FAVORITE (Flow and Volume Controlled Inhalation

The US-based pharmaceutical company has appealed against the 5 April order that dismissed its plea for limiting Glenmark Pharmaceuticals from producing and marketing drugs Zita and Zita-Met indicated

Previously, the US Secretary of Health and Human Services has asked the Food and Drug Administration (FDA) to reject Teva Pharmaceutical’s petition to make its Plan B and

The completion of construction will be followed by GMP certification at the provincial level, according to the company. The 53,000mt2 pre-extraction plant will perform initial processing of traditional

Operations at the 55,000ft2 GCP-compliant facility are expected to commence in August 2013. Novum chief executive officer Christopher Chamberlain said, "Like our other research facilities, it will provide

The grant will provide $2.2m over three years to develop a recombinant tetravalent dengue vaccine using VaxInnate’s proprietary technology, which includes genetically fusing vaccine antigens to the bacterial

As part of the agreement, KannaLife will fund a new drug discovery project related to a laboratory validated phytochemical. The founding science is based on the licensed technology

The two primary endpoints of OSKIRA-1were evaluation of signs and symptoms of RA as measured by ACR20 response rates, and an X-ray endpoint referred to as modified Total

The company completed Phase I safety trial of NSI-566 stem cells in ALS and also won orphan drug designation. Upon FDA approval, a Phase II trial is scheduled